Company: SMNR
Filing Date: 2025-07-23
Form Type: S-4/A
Source: 0001193125-25-163401
Chunk: 2

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-23
Form: S-4/A
Chunk 2
---
ant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

TABLE OF CO-REGISTRANTS

| Exact Name ofCo-Registrantas Specified in its Charter(1)(2) |     | State or OtherJurisdiction ofIncorporation orOrganization |          |     | PrimaryStandardIndustrialClassificationCode Number |      |     | I.R.S. EmployerIdentification Number |            |
| Semnur Pharmaceuticals, Inc.                                |     |                                                           | Delaware |     |                                                    | 2836 |     |                                      | 46-2968523 |

(1) The Co-Registranthas the following principal executive office: Semnur Pharmaceuticals, Inc. 960 San Antonio Road Palo Alto, CA 94303 (2) The agent for service for the Co-Registrantis: Jaisim Shah Chief Executive Officer and President Semnur Pharmaceuticals, Inc. 960 San Antonio Road Palo Alto, CA 94303 (650) 516-4310

<div align='center'>**EXPLANATORY NOTE**</div>

This registration statement contains two prospectuses, as set forth below.

| • |     | Primary Offering Prospectus. A primary offering prospectus of Denali Capital Acquisition Corp. with respect to the issuance of up to 292,476,239 shares of Common Stock, 524,622 Public Units, 6,000,000 shares of Series A Preferred Stock and 8,760,000 Warrants of Denali Capital Acquisition Corp. in connection with the completion of the Business Combination; and |

| • |     | Resale Prospectus. A resale prospectus with respect to the resale by the Selling Stockholders named therein of up to 201,118,000 shares of New Semnur Common Stock. |

The resale prospectus is substantively identical to the primary offering prospectus, except for the following:

| • |     | the resale prospectus contains a different cover page; |

| • |     | a “Selling Stockholder” section is included in the resale prospectus; and |

| • |     | a “Plan of Distribution” section is included in